Drugs / homatropine
last change Oct 2014 re-read 9 days ago

homatropine

Small molecule

Investigated by
EMS

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT01408069 — — EMS Withdrawn No outcome recorded Stop: Business
Comparator or background therapy2 trials
Phase 1 NCT01168375 Comparator — corneal disorder Shahid Beheshti University of Medical Sciences Unknown No outcome recorded
— NCT02344732 Background Oct 2013 → Oct 2014 corneal disorder Universiti Sains Malaysia Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as homatropine “1 to 2 tablets ergotamine 1mg + caffeine 100mg + acetylsalicylic 350 mg + homatropine 1,2 mg” NCT01408069 ↗
2

“cycloplegic (homatropine) eye drop every 8 hours” NCT01168375 ↗

NCT02344732 ↗

Known as Dl-homatropine hydrobromide ChEMBL registry synonym — accepted as the source's own label CHEMBL1618018 ↗
Known as HOMATROPINE HYDROBROMIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL1618018 ↗
Known as Homatropini hydrobromidum ChEMBL registry synonym — accepted as the source's own label CHEMBL1618018 ↗
Known as NSC-757047 ChEMBL registry synonym — accepted as the source's own label CHEMBL1618018 ↗
Modality Small molecule — CHEMBL1618018 ↗
Route Other “cycloplegic (homatropine) eye drop every 8 hours” NCT01168375 ↗